hero image

Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference

February 18, 2014 News Release

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the 2014 RBC Capital Markets’ Healthcare Conference. The webcast will be live on Tuesday, February 25, 2014 at 10:30 a.m. ET. To access the live webcast, please visit Biogen Idec’s Investors section at www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $6 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.

Contact:

 

Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations

thumb
June 6, 2023
Biogen Withdrawal from the Jefferies Healthcare Conference

Cambridge, MA, - -  Biogen Inc. (Nasdaq: BIIB) announced today that it will not participate in the Jefferies Healthcare Conference on Wednesday, June 7, 2023. About Biogen Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations

thumb
June 1, 2023
Biogen Announces Webcast of Annual Meeting of Stockholders

Cambridge, Mass. – June 1, 2023 – Biogen Inc. (Nasdaq: BIIB) announced today that the webcast of the Company's 2023 Annual Meeting of Stockholders will be held on Wednesday, June 14, 2023, at 9:00 a.m. Eastern Time.  A live audio webcast of the meeting will be available on the Investor Relations